LENZ
NASDAQ · Pharmaceuticals
Lenz Therapeutics Inc
$5.75
-0.07 (-1.20%)
Open$5.79
Previous Close$5.82
Day High$5.93
Day Low$5.73
52W High$50.40
52W Low$5.84
Volume—
Avg Volume528.9K
Market Cap192.83M
P/E Ratio—
EPS$-3.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+143.1% upside
Current
$5.75
$5.75
Target
$13.98
$13.98
$9.74
$13.98 avg
$16.17
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 21.73M | 61.59M | 55.54M |
| Net Income | -93,473,130 | 19.38M | 14.59M |
| Profit Margin | -430.3% | 31.5% | 26.3% |
| EBITDA | -103,403,195 | 32.48M | 26.94M |
| Free Cash Flow | — | 24.80M | 19.95M |
| Rev Growth | — | +17.7% | +18.8% |
| Debt/Equity | — | 0.99 | 1.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |